PEG-MGF (PEGylated Mechano Growth Factor) is a modified form of MGF (Mechano Growth Factor) with polyethylene glycol (PEG) molecules attached. The PEGylation dramatically extends the half-life of MGF from minutes to potentially hours, allowing for systemic distribution and prolonged activity. While native MGF acts locally and briefly to activate satellite cells, PEG-MGF can circulate in the bloodstream and affect muscle tissue throughout the body. This modification trades the natural localized action of MGF for broader systemic effects, making it suitable for research requiring extended exposure to MGF activity.
| Research Status | Research chemical |
|---|---|
| Half-Life | Several days |
| Administration | Subcutaneous injection |
| Typical Dosage | 200 mcg 2-3x per week |
| Molecular Weight | Variable based on PEG size (typically 5-40 kDa added) |
| Molecular Formula | Variable (MGF + polyethylene glycol chains) |
Same as MGF with PEG attachment for extended circulation time and systemic distribution.
All information is presented for Research Use Only (RUO). Not medical advice.